Clinical Trial: Haemocomplettan® P During Elective Complex Cardiac Surgery

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Efficacy and Safety of Haemocomplettan® P in Patients Experiencing Microvascular Bleeding While Undergoing Elective Complex Cardiac Surgery

Brief Summary: Fibrinogen concentrate is increasingly used in cardiac surgery to reverse coagulopathy. Whether its use reduces blood loss, transfusion and occurrence of clinical adverse events remains unknown.